Overall Technical outlook

Price Summary

On 2026-04-09, GlaxoSmithKline Pharmaceuticals Limited's stock began at 2354.3, climbed to 2374.3, dropped to 2345.0, and had 0.23% to end at 2359.7, with a volume of 23610 shares.
During the 52-week span, the stock hit a high of 3466.2 and a low of 0.0.
4 analysts estimate that the future price of GLAXO will fall between 2700.0 and 3500.0, with an average price expectation of approximately 3064.5.

Technicals

Support and Resistance: The current price of 2359.7 is supported at 2278.5, with resistance at 2384.2. This suggests that the price for GLAXO might remain between these levels, where 2278.5 acts as a floor and 2384.2 as a ceiling in the market.
GLAXO supportResistance cd1c92
Support/Resistance for GLAXO


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
GLAXO aroon cd1c92
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAXO bbands cd1c92
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish, setting a critical support level that may help sustain the market's upward trend. This persistent bullish outlook suggests that the market is likely to continue climbing, with the support level offering a foundation for further growth.
GLAXO psar cd1c92
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
GLAXO stoch cd1c92
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
GLAXO trippleSMA cd1c92
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


To make the most of a company's technical analysis, it's important to start with an understanding of its fundamentals. These include profitability, cash flow, and competitive positioning. Additionally, the industry in which the company operates plays a critical role, as trends and external factors can influence its market performance. By considering both the company's internal fundamentals and the external industry environment, more meaningful and accurate conclusions can be drawn from the technical data.